National Diabetes Week 2022: Diabetes stigma and your mental health
Did you know that four out of every five people living with diabetes have experienced stigma?
A 2021 study by the Australian Centre for Behavioural Research in Diabetes found that more than 80% of people with diabetes “have been judged, blamed, shamed, or treated differently due to their diabetes”. This can, in turn, often lead to a negative impact on the mental health and wellbeing of those living with diabetes.
During National Diabetes Week 2022, JDRF Australia is shining a light on this stigma and the effects it can have on the emotional wellbeing of those living with T1D.
We’ll be sharing lots of advice and resources to help support the mental health of those living with T1D, as well as information to help break the stigma around this often misunderstood condition.
You are not alone
You don’t need to be in crisis mode to find support and work on your mental health. You can join a support group (JDRF Australia runs Facebook groups for parents/carers of those newly diagnosed with T1D, and for people with T1D who are aged 14-24 years, or 25 and over.
You might like to join our Peer Support Program to chat with someone who knows what it’s like to live with T1D.
You can also check out our guide to where to find mental health support.
This National Diabetes Week, we’ll be sharing handy resources and information to help those living with T1D.
Keep an eye on our Facebook page, our Instagram and Twitter to find all our practical articles and posts to help break the stigma and support the mental health and wellbeing of those living with T1D.
JDRF welcomes decision to extend availability of Fiasp on the PBS
MEDIA RELEASE JDRF Australia welcomes Government’s decision to extend availability of Fiasp insulin on the Pharmaceutical Benefits Scheme The move will keep the life-saving medication in the hands of the 15,000+ people who rely on it for a further six months Sydney, 17 March 2023: JDRF Australia is today welcoming an announcement by the Albanese […]
Your child’s return to school after a type 1 diabetes diagnosis
The days, weeks and months following your child’s type 1 diabetes (T1D) diagnosis are full of firsts. And one of the biggest milestones your family will work towards is your child’s first day back at preschool or school. You’ll no doubt be feeling uncertain and will have many questions in the lead up to their […]
Dr. Ki Wook Kim On Developing Vaccines To Prevent Type 1 Diabetes
“The ultimate goal is to help develop vaccines to prevent T1D, as well as antiviral therapeutics to potentially treat people already diagnosed with T1D” Dr Kim’s work aims to uncover the link between viruses and type 1 diabetes (T1D). As one of the lead investigators of ENDIA, Dr Kim is looking at whether early infection […]
Scheduled removal of Fiasp from the Pharmaceutical Benefits Scheme
JDRF Australia are aware that Fiasp insulin is currently scheduled for removal from the Pharmaceutical Benefits Scheme from 1 April 2023. If removed at this date, it will no longer be available at a subsidised cost however will reportedly be available privately for a period of time. This is a significant concern to us and for many […]